12:00 AM
 | 
Aug 03, 2015
 |  BC Week In Review  |  Company News  |  Deals

AstraZeneca, INSERM deal

AstraZeneca plc (LSE:AZN;NYSE:AZN), London, U.K.
French National Institute of Health and Medical Research, Paris, France
Business: Renal, Endocrine/Metabolic
AstraZeneca and The French National Institute...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >